Manhattan Scientifics, Inc.
The Chrysler Building, 32nd Floor
405 Lexington Avenue
New York
New York
10174
United States
Tel: 212-551-0577
Fax: 212-752-0077
Website: http://www.mhtx.com/
47 articles about Manhattan Scientifics, Inc.
-
Manhattan Scientifics Announces Early Results from Cancer Company
3/17/2022
Manhattan Scientifics Inc. ( OTCQB: MHTX ), announces positive early results from Imagion Biosystems Cancer Diagnostic human study.
-
Manhattan Scientifics Cancer Imaging Asset Announces Progress on Australian Clinical Study
11/1/2021
Manhattan Scientifics Inc., initially funded and is the current owner of more that 50 million shares of Imagion Biosystems Ltd..
-
Manhattan Scientifics Inc. Stock Chart Mimics That of Its Largest Investment to Date: Imagion Biosystems
3/11/2021
Manhattan Scientifics Inc. invested $30 million and a 10-year effort to commercialize the Imagion Biosystems super early, non- invasive, non-radioactive Cancer diagnostic, now “partnered” with MD Anderson Cancer Center, Houston.
-
Manhattan Scientifics Issues Year End Update - Feb 09, 2021
2/9/2021
Manhattan Scientifics Inc. a company that acquires, develops and commercializes life-enhancing technologies is pleased to announce year-end business updates on its two nano technologies for 2020: its Nano-Medicine Cancer and Nano-Medical Metal Alloy ventures.
-
Manhattan Scientifics Features Early Cancer Detection Technology
11/10/2020
Manhattan Scientifics Inc. (MHTX: OTCQB) provides a 45-minute interview with Imagion Biosystems Chairman/CEO Bob Proulx describing the very-early-cancer-diagnostic development that MHTX incubated and helped to go public on the Australian stock exchange: IMAGION BIOSYSTEMS LTD.
-
Manhattan Scientifics Announces Rising Price & Volume
8/13/2020
Manhattan Scientifics, Inc. (OTCQB:MHTX) owns 50+ Million shares of its former wholly-owned subsidiary cancer diagnostic company Imagion Biosystems Ltd. (AX:IBX).
-
Manhattan Scientifics Seed Funded Imagion Bioscience & Owns 64 Million Shares IBX
7/25/2019
Manhattan Scientifics (OTC; QB MHTX) announces its former wholly owned sub Imagion Bioscience (ASX:IBX) Receives A$2 million in R&D Tax Incentives from the Australian Government (ATO)
-
Manhattan Scientifics Updates its Previous July 19th Press Release
7/22/2019
Manhattan Scientifics (OTC: QB MHTX) clarifies that it continues to own 64 million shares of Imagion Biosystems Ltd (ASX: IBX)
-
Manhattan Scientifics Announces Breakthrough Device for Detection of Cancer
7/18/2019
Manhattan Scientifics Inc.’s (OTC: QB MHTX) former wholly-owned subsidiary that was initially funded by MHTX, Imagion Biosystems Ltd (ASX:IBX) over a nine-year period has received confirmation from the Food and Drug Administration (FDA) that the MagSense System and Test for staging HER2 breast cancer has qualified for and been granted designation as a breakthrough device
-
Manhattan Scientifics Prepares for Future: Considers Acquisition and Path to Uplisting
7/9/2019
Manhattan Scientifics will enter its third phase of activity – to acquire a substantial technology company and to uplist MHTX to a national securities exchange such as the Nasdaq Capital Market.
-
Manhattan Scientifics Completes Licensing Deal for its Patented Metals Nanotechnology
5/2/2019
Manhattan Scientifics Inc., is pleased to announce that the company has completed an exclusive license and transfer of specialty machines to a large American metals manufacturer who provides specialty metals to the U.S. and global medical industry.
-
Manhattan Scientifics, Inc. Release: MHTX Provides Corporate Update
10/5/2017
-
Manhattan Scientifics, Inc. Announces Successful Completion Of Its Affiliate Imagion Biosystems IPO
6/22/2017
-
Manhattan Scientifics, Inc. Schedules Investor Conference Call On Its Affiliate, Imagion Biosystems IPO
6/15/2017
-
Manhattan Scientifics, Inc. Affiliate Files For Initial Public Offering On Australian Stock Exchange
6/1/2017
-
Manhattan Scientifics, Inc. Announces Retirement Of Its Current $2.5 Million Long Term Debt And Proudly States That It Now Has A Virtually Zero-Debt Balance Sheet
2/13/2017
-
Manhattan Scientifics, Inc. Announces Agreement To Spin-Off And IPO Its Senior Scientific Unit
11/29/2016
-
Ex-GE Healthcare CTO Michael J. Harsh Joins Manhattan Scientifics, Inc. Advisory Board
3/29/2016
-
Manhattan Scientifics, Inc. Announces Chinese Patent Issued For The Early Cancer Detection Technology Platform
10/26/2015
-
Manhattan Scientifics, Inc. Announces Issuance Of Additional Patent Covering Detection And Imaging Of Cancer Cells
8/10/2015